FDC Int recalls a batch of sodium cromoglicate eye drops and of Murine Hayfever Relief

FDC Int recalls a batch of sodium cromoglicate eye drops and of Murine Hayfever Relief

July 31 2018 A class 3 recall for sodium cromoglicate 2% w/v eye drops and Murine Hayfever Relief...

Effect of omega-3 on heart disease is negligible, finds Cochrane review

Effect of omega-3 on heart disease is negligible, finds Cochrane review

July 19 2018 Cochrane researchers have published research indicating that omega 3 supplements...

BLF highlights decline in stop smoking prescriptions

BLF highlights decline in stop smoking prescriptions

July 18 2018 There has been a 75% decline in stop smoking treatments being prescribed by GPs and...

Welsh National Survey includes OTC medicine purchases for first time

Welsh National Survey includes OTC medicine purchases for first time

June 28 2018 Over half the population in Wales has reported having bought an over the counter...

Recall issued for several own label glycerine and blackcurrant cough syrups

Recall issued for several own label glycerine and blackcurrant cough syrups

June 20 2018 A Class 2 Drug Recall has been issued for 15 batches of own-brand children’s...

  • FDC Int recalls a batch of sodium cromoglicate eye drops and of Murine Hayfever Relief

    FDC Int recalls a batch of sodium cromoglicate eye drops and of Murine Hayfever Relief

    Tuesday, 31 July 2018 15:24
  • Effect of omega-3 on heart disease is negligible, finds Cochrane review

    Effect of omega-3 on heart disease is negligible, finds Cochrane review

    Thursday, 19 July 2018 10:21
  • BLF highlights decline in stop smoking prescriptions

    BLF highlights decline in stop smoking prescriptions

    Wednesday, 18 July 2018 17:32
  • Welsh National Survey includes OTC medicine purchases for first time

    Welsh National Survey includes OTC medicine purchases for first time

    Thursday, 28 June 2018 16:55
  • Recall issued for several own label glycerine and blackcurrant cough syrups

    Recall issued for several own label glycerine and blackcurrant cough syrups

    Wednesday, 20 June 2018 18:29

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

supplementsJune 20 2016

Consumers’ association Which? has challenged dietary supplement products which suggest they can help improve brain health. In particular, they have raised concerns that products are suggesting they can help reduce the risk of dementia.

The Which? panel of experts including a dietitian, a GP and a professor of public health medicines, have looked at a number of services and products. They concluded that “there is no robust evidence that the vitamins, plant extracts and other ‘functional’ ingredients commonly used in these supplements can reduce the risk of dementia.”

Which? has reported one product’s claims to the Advertising Standards Authority, and has said the panel was also sceptical of online and in person tests and investigations that try to spot mild cognitive impairment. It says people using these may have to pay more than £1,000.

Its review of products of products to avoid highlights four supplements and one app, saying the experts “do not believe the science doesn’t stack up.” Ingredients attributed to any brain function improvement but challenged by the panel included omega-3 fatty acids such as docosahexaenoic acid (DHA) at higher concentrations, Ginkgo biloba, B vitamins, and N-acetylcysteine.

“It’s unacceptable that some companies are preying on people’s fears, making claims they simply can’t back up,” said Which? Director of Policy and Campaigns Alex Neill. “For people worried about dementia our advice is you don’t need to spend time and money on expensive supplements or products, like online tests or apps. There are many alternative sources of free, independent information and advice that can help you to understand your options and next steps.”

Links:

Which? announcement

Which? opinion

OTC News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...